2026-117 — Commercial Office with research laboratory and pharmaceutical manufacturing in Irving, TX
This rezoning case involves converting a 2.485-acre restaurant/hotel site plan (S-P-1) to a commercial office site plan (S-P-2) to accommodate pharmaceutical research and manufacturing uses. The public hearing is scheduled for June 11, 2026 before City Council, and developers with interests in pharmaceutical or biotech development in the Irving area should monitor this approval status as it may affect competitive positioning and land availability in the market.
| Case number | 2026-117 |
|---|---|
| Type | Rezoning |
| Location | 1320 Greenway Dr, Irving, TX 75038 |
| Acreage | 2.485 |
| Current zoning | S-P-1 (R-AB) |
| Requested zoning | S-P-2 (C-O) |
| Proposed use | Commercial Office with research laboratory and pharmaceutical manufacturing |
| Petitioner | Masterplan Consultants |
| Owner | NB Greenway LLC |
| Hearing | 2026-06-11 |
| Hearing body | City Council |
| Status | new |
Tracking this case? Zoning Firehose emails you the moment cases like this hit any DFW P&Z agenda — days before the hearing. Start a free trial.